BLATAM
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy (NCT06972615) | BLATAM | 2026-05-21 |
Track BLATAM automatically
Every clearance here is in the API, with alerts when new ones post.